Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia

Clinical trial NCT02100839 · COMPLETED

Trial details

NCT number: NCT02100839
Sponsor: LipimetiX Development, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia Hyperlipoproteinemia Type II

Start date: 2014-03-01
Primary completion: 2014-11-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.